The Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS) is an international multicenter randomized trial, the primary aims of which are: (1) to determine the risks and benefits of carotid and vertebral artery transluminal angioplasty; and (2) to compare these with surgical treatment (carotid endarterectomy) or best medical treatment. Through the end of October 1995, 193 patients have been randomized (90 at our center). In this article, the rationale for the trial, its design and protocol, and the experience of our institution within the trial will be discussed.
WarlowC. Secondary prevention of stroke. Lancet Stroke Octet1992:35–37.
2.
DennisMBamfordJSandercockP. Prognosis of transient ischaemic attacks in the Oxfordshire Community Stroke Project. Stroke1990;21:848–853.
3.
North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high grade carotid stenosis. N Engl J Med1991;325:445–453.
4.
European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: Interim results for symptomatic patients with severe (70–99%) or with mild (–29%) carotid stenosis. Lancet1991;337:1235–1241.
